4 ms·
This has a lot to do with the oligopoly in pharmacy benefit managers. top 3 PBMs account for 79% of all prescriptions dispensed in 2020. These companies in turn
by anizan 3y ago
This has a lot to do with the oligopoly in pharmacy benefit managers. top 3 PBMs account for 79% of all prescriptions dispensed in 2020.
These companies in turn negotiate hard with generic manufacturers that often they sell at a loss and aren't motivated to produce for America.
- patmorgan23 3y agoYeah, kick backs/rebates to PBMs should be illegal. The only compensation they should get is from the insurance plan that hired them to negotiate on their behalf. Even then PBMs are always going to be a centralizing force in the drug market leading toward a monopsony(single buyer market). Buying power is going to distort faster than large sells (10% of market buying force is very powerful, will 10% of marketing selling share is big but can be worked around)